Literature DB >> 21097699

Replication error deficient and proficient colorectal cancer gene expression differences caused by 3'UTR polyT sequence deletions.

Jennifer L Wilding1, Simon McGowan, Ying Liu, Walter F Bodmer.   

Abstract

Replication error deficient (RER+) colorectal cancers are a distinct subset of colorectal cancers, characterized by inactivation of the DNA mismatch repair system. These cancers are typically pseudodiploid, accumulate mutations in repetitive sequences as a result of their mismatch repair deficiency, and have distinct pathologies. Regulatory sequences controlling all aspects of mRNA processing, especially including message stability, are found in the 3'UTR sequence of most genes. The relevant sequences are typically A/U-rich elements or U repeats. Microarray analysis of 14 RER+ (deficient) and 16 RER- (proficient) colorectal cancer cell lines confirms a striking difference in expression profiles. Analysis of the incidence of mononucleotide repeat sequences in the 3'UTRs, 5'UTRs, and coding sequences of those genes most differentially expressed in RER+ versus RER- cell lines has shown that much of this differential expression can be explained by the occurrence of a massive enrichment of genes with 3'UTR T repeats longer than 11 base pairs in the most differentially expressed genes. This enrichment was confirmed by analysis of two published consensus sets of RER differentially expressed probesets for a large number of primary colorectal cancers. Sequence analysis of the 3'UTRs of a selection of the most differentially expressed genes shows that they all contain deletions in these repeats in all RER+ cell lines studied. These data strongly imply that deregulation of mRNA stability through accumulation of mutations in repetitive regulatory 3'UTR sequences underlies the striking difference in expression profiles between RER+ and RER- colorectal cancers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21097699      PMCID: PMC3000307          DOI: 10.1073/pnas.1015604107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  HuR and mRNA stability.

Authors:  C M Brennan; J A Steitz
Journal:  Cell Mol Life Sci       Date:  2001-02       Impact factor: 9.261

Review 2.  The cap-to-tail guide to mRNA turnover.

Authors:  C J Wilusz; M Wormington; S W Peltz
Journal:  Nat Rev Mol Cell Biol       Date:  2001-04       Impact factor: 94.444

Review 3.  Regulation of mRNA stability in the nervous system and beyond.

Authors:  J S Malter
Journal:  J Neurosci Res       Date:  2001-11-01       Impact factor: 4.164

4.  Messenger RNA degradation: beginning at the end.

Authors:  Ambro van Hoof; Roy Parker
Journal:  Curr Biol       Date:  2002-04-16       Impact factor: 10.834

Review 5.  Post-transcriptional regulation of gene expression by degradation of messenger RNAs.

Authors:  Annamaria Bevilacqua; Maria Cristina Ceriani; Sergio Capaccioli; Angelo Nicolin
Journal:  J Cell Physiol       Date:  2003-06       Impact factor: 6.384

6.  Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.

Authors:  R Gryfe; H Kim; E T Hsieh; M D Aronson; E J Holowaty; S B Bull; M Redston; S Gallinger
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

Review 7.  Deficient DNA mismatch repair: a common etiologic factor for colon cancer.

Authors:  P Peltomäki
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

Review 8.  Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory roles.

Authors:  Arindam Chaudhury; Praveen Chander; Philip H Howe
Journal:  RNA       Date:  2010-06-28       Impact factor: 4.942

9.  SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.

Authors:  K L Woodford-Richens; A J Rowan; P Gorman; S Halford; D C Bicknell; H S Wasan; R R Roylance; W F Bodmer; I P Tomlinson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 10.  Role of DNA mismatch repair defects in the pathogenesis of human cancer.

Authors:  Päivi Peltomäki
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

View more
  5 in total

1.  Solute exchange through gap junctions lessens the adverse effects of inactivating mutations in metabolite-handling genes.

Authors:  Stefania Monterisi; Johanna Michl; Alzbeta Hulikova; Jana Koth; Esther M Bridges; Amaryllis E Hill; Gulnar Abdullayeva; Walter F Bodmer; Pawel Swietach
Journal:  Elife       Date:  2022-09-15       Impact factor: 8.713

2.  Critical roles for EGFR and EGFR-HER2 clusters in EGF binding of SW620 human carcinoma cells.

Authors:  Adam J M Wollman; Charlotte Fournier; Isabel Llorente-Garcia; Oliver Harriman; Alex L Payne-Dwyer; Sviatlana Shashkova; Peng Zhou; Ta-Chun Liu; Djamila Ouaret; Jenny Wilding; Akihiro Kusumi; Walter Bodmer; Mark C Leake
Journal:  J R Soc Interface       Date:  2022-05-25       Impact factor: 4.293

Review 3.  Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome).

Authors:  Daniel D Buchanan; Christophe Rosty; Mark Clendenning; Amanda B Spurdle; Aung Ko Win
Journal:  Appl Clin Genet       Date:  2014-10-06

Review 4.  Oxidative Stress Modulation and ROS-Mediated Toxicity in Cancer: A Review on In Vitro Models for Plant-Derived Compounds.

Authors:  María José Vallejo; Lizeth Salazar; Marcelo Grijalva
Journal:  Oxid Med Cell Longev       Date:  2017-10-24       Impact factor: 6.543

Review 5.  Lynch-like Syndrome: Potential Mechanisms and Management.

Authors:  Alejandro Martínez-Roca; Mar Giner-Calabuig; Oscar Murcia; Adela Castillejo; José Luis Soto; Anabel García-Heredia; Rodrigo Jover
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.